In the ongoing effort to combat cardiovascular disease—the leading cause of death in the United States—medical professionals have increasingly relied on advanced screening tools to identify "silent" threats. Among these, the coronary artery calcium (CAC) scan has emerged as a popular, quick, and relatively affordable CT test designed to visualize calcified plaque buildup within the arteries.
However, a landmark study published August 26 in the journal JAMA suggests that the clinical utility of these scans is far more nuanced than previously assumed. Researchers from Northwestern Medicine have determined that while the CAC scan is a powerful diagnostic instrument, its value is optimized only for a specific subset of the population. For many others, the test may offer little incremental benefit over standard risk-assessment tools, potentially leading to unnecessary radiation exposure and medical costs.
The Evolution of Risk Assessment: PREVENT vs. Imaging
To understand the impact of these findings, one must look at how cardiologists currently calculate the probability of a future heart attack or stroke. For years, the gold standard has been the use of risk calculators—algorithms that synthesize clinical data such as age, sex, blood pressure, and cholesterol levels. The American Heart Association’s latest iteration, the PREVENT (Predicting Risk of Cardiovascular Disease Events) calculator, has become the cornerstone of modern primary prevention.
While the PREVENT tool relies on systemic health markers to project risk over a 10- or 30-year horizon, the coronary artery calcium scan takes a "bottom-up" physical approach. By utilizing CT imaging to detect calcium-containing plaque directly inside the coronary arteries, the scan provides a physical score: the higher the calcium volume, the higher the presumed risk of future cardiac events.
For years, the medical community has debated how to best integrate these two approaches. Should everyone receive a scan to "see" what is happening inside their heart, or is the reliance on biological markers sufficient? The new Northwestern study provides the most robust evidence to date that the answer is a matter of precision, not universality.
Chronology of the Study: Tracking a Decade of Cardiovascular Health
The research team, led by senior author Dr. Nilay Shah, an assistant professor of medicine in the division of cardiology at the Northwestern University Feinberg School of Medicine, sought to quantify exactly how much information the calcium scan adds to the standard PREVENT assessment.
The investigation utilized data from the Multi-Ethnic Study of Atherosclerosis (MESA), a high-quality, long-term observational study. The researchers followed a cohort of more than 6,000 adults, aged 45 to 79, over a 10-year period.
Phase 1: Baseline Assessment
At the onset of the study, each participant underwent a dual evaluation. First, their cardiovascular risk was calculated using the PREVENT equations based on their demographic and metabolic health data. Second, each participant underwent a coronary artery calcium scan to determine their plaque burden score.
Phase 2: The Longitudinal Follow-Up
For the subsequent decade, researchers tracked the participants to see who would experience a major cardiovascular event, such as a heart attack or stroke. During the 10-year span, approximately 6% of the cohort suffered such an event.
Phase 3: Comparative Analysis
The final phase involved comparing the predictive accuracy of two models: one that relied solely on the PREVENT calculator and one that combined the PREVENT score with the CAC imaging data. The findings were striking in their lack of dramatic improvement across the entire population, yet they were profoundly significant when the data was stratified by risk level.
Supporting Data: When the Numbers Matter
The study’s statistical findings provide a clear map for clinicians deciding when to order a scan. The model’s "discrimination"—a measure of its ability to correctly distinguish between patients who will experience a cardiovascular event and those who will not—showed only a marginal increase when the calcium scan was added to the PREVENT calculator. The score rose from 0.73 (using PREVENT alone) to 0.75 (when the scan was added).
However, the "modest" overall improvement masked a critical trend. When researchers zoomed in on the "borderline" or "intermediate" risk groups—individuals who, according to the PREVENT calculator, have a 3% to 9% risk of a cardiac event over the next 10 years—the value of the calcium scan became clear.
For these specific patients, the scan acts as a tie-breaker. It provides the granular data necessary to "reclassify" a patient. A person who appears to be at moderate risk on paper might be found to have a high calcium score, indicating an urgent need for statins or other interventions. Conversely, someone who appears moderate might have a zero calcium score, suggesting that their risk is lower than estimated and that they might not need aggressive lipid-lowering therapy.
Official Responses and Clinical Perspectives
Dr. Nilay Shah and his co-authors emphasize that their findings are not a condemnation of calcium scans, but rather a call for clinical stewardship.
"Coronary artery calcium scans are becoming more widely available and less expensive," Dr. Shah noted. "Our findings suggest that not everyone necessarily needs or would benefit from a coronary artery calcium scan for the purpose of predicting risk of heart attack and stroke."
The research highlights a "Goldilocks" problem in current clinical practice:
- Low-Risk Patients: For those at very low risk, a scan is likely unnecessary. It adds the burden of radiation exposure and financial costs without providing actionable data that would change the standard of care.
- High-Risk Patients: For those already identified as high-risk, the scan is often redundant. Because their clinical profile already warrants aggressive preventive treatment (such as statins), the result of the scan is unlikely to change the physician’s management strategy.
"Routinely using a calcium scan in people who are at low risk may result in unnecessary radiation exposure, testing and costs with unclear clinical benefits," Dr. Shah added. "Using calcium scans in people who are at high risk is likely to result in unnecessary testing because these individuals are recommended to start a statin regardless of what the calcium scan shows."
The research reinforces the importance of the PREVENT calculator, which demonstrated strong predictive performance on its own. The study was a collaborative effort involving a team of experts, including Xiaoning Huang, Lucia Petito, Norrina Allen, Dr. Philip Greenland, and Dr. Sadiya Khan, highlighting a robust consensus within the Northwestern team regarding the utility of these risk-stratification tools.
Implications for Future Medical Practice
The implications of this study are far-reaching for primary care physicians and cardiologists alike. If clinicians adopt this targeted approach, they can reduce unnecessary medical procedures while focusing diagnostic resources on the patients most likely to see a shift in their treatment plan.
Addressing Health Disparities
While the current study provides a foundation, the authors acknowledge that there is more work to be done. A crucial area for future research involves diverse populations. Dr. Shah noted that the utility of calcium scores in specific groups—such as South Asian and Filipino adults, who may have different risk profiles—remains an area requiring further investigation. Additionally, because the study participants were aged 45 to 79, the role of these scans in younger, "at-risk" populations remains an open question.
The Shift Toward Precision Prevention
Ultimately, the study supports a shift toward "precision prevention." By using the PREVENT calculator as a primary filter, doctors can determine whether a patient occupies the "gray zone" of risk. If a patient is clearly at low risk or clearly at high risk, the clinical path is often clear. If the patient sits in the middle, that is when the imaging technology provides the most value, acting as a diagnostic pivot point that justifies the cost and radiation of the scan.
A New Standard of Care?
As medical technology continues to advance, the temptation to use every tool available is strong. However, this study serves as a necessary reminder that the most "advanced" test is not always the best test for every patient. By integrating sophisticated software-based calculators with targeted imaging, clinicians can provide more accurate, cost-effective, and safe care for the millions of Americans striving to prevent heart disease.
The study, titled "Predictive Utility of Coronary Artery Calcium Added to the PREVENT Atherosclerotic Cardiovascular Disease Equations," was supported by significant grants from the American Heart Association and the National Heart, Lung, and Blood Institute. As these findings permeate clinical guidelines, they are expected to foster a more disciplined and effective approach to one of the most common diagnostic procedures in cardiology.
